About Nacuity Pharmaceuticals
Advancing a promising treatment for retinitis pigmentosa
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
nacuity.com
Domain Registered Date
Aug 10, 2016
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Milestone
X account created (@nacuitypharma)
87 followers
- Capital Raise
Raised $16,500,000 · Series-B+
startupintros.com
- Milestone
Website domain registered
nacuity.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Nacuity Pharmaceuticals.
Funding History
Series-B+
· Jun 16, 2022
$16,500,000 startupintros.com
Founders & Leadership
Halden Conner
Co-Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026